Capula Management Ltd
Q3 2023 13F-HR Holdings
Net value change ($000)
+670,216
(16.4%)
New positions
216
Sold out positions
167
Turnover %
46.7%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SPY | 534,687 | 333.4% |
| GOOGL | 95,545 | 191.5% |
| AMZN | 86,189 | NEW |
| AIY | 33,707 | NEW |
| AAPL | 28,567 | NEW |
| Horizon Therapeutics Public Ltd Co | 21,355 | 321.2% |
| UPS | 18,368 | 3826.7% |
| Seagen Inc. | 14,638 | NEW |
| NEW RELIC, INC. | 14,035 | NEW |
| CPRI | 9,996 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| VCIT | -189,785 | -100.0% |
| QQQ | -50,120 | -49.1% |
| EEM | -10,294 | -100.0% |
| DICE Therapeutics, Inc. | -9,933 | -100.0% |
| IVERIC bio, Inc. | -8,320 | -100.0% |
| Univar Solutions Inc. | -6,505 | -100.0% |
| Syneos Health, Inc. | -6,005 | -100.0% |
| SBUX | -5,437 | -75.6% |
| ABBV | -4,527 | -100.0% |
| BMY | -4,515 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
3,232,318
(67.8% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|